Inhibition of the human two‐pore domain potassium channel, TREK‐1, by fluoxetine and its metabolite norfluoxetine
Louise E Kennard(Imperial College London), Alistair Mathie(University of Westminster), Justin Chumbley(Imperial College London), Emma L. Veale(Medway School of Pharmacy), Kishani M. Ranatunga(Imperial College London), Stephanie J. Armstrong(Imperial College London)
Cited by 200
Related Papers
Guide to Receptors and Channels (GRAC), 5th edition
|British Journal of Pharmacology|2011|1.9k
THE CONCISE GUIDE TO PHARMACOLOGY 2019/20: G protein‐coupled receptors
|British Journal of Pharmacology|2019|712
Guide to Receptors and Channels (GRAC), 3rd edition
|British Journal of Pharmacology|2008|508
THE CONCISE GUIDE TO PHARMACOLOGY 2019/20: Enzymes
|British Journal of Pharmacology|2019|505
THE CONCISE GUIDE TO PHARMACOLOGY 2021/22: G protein‐coupled receptors
|British Journal of Pharmacology|2021|488